Legal Representation
Attorney
Russell C Gache
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 15, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 15, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 30, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 30, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 1, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 1, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 1, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 24, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 23, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 23, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 11, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 11, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
providing clinical research start-up site management services
First Use Anywhere:
Mar 1, 2024
First Use in Commerce:
Mar 1, 2024
Additional Information
Design Mark
The mark consists of the literal element medovation followed by a period punctuation mark positioned above the literal element clinical research in upper case font.
Pseudo Mark
MEDICAL INNOVATION; MEDICINE INNOVATION
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL RESEARCH"